Table 3 Comorbidities of NTM lung disease
From: Characterization of non-tuberculous mycobacterial pulmonary disease in Nanjing district of China
Comorbidities No. of isolates | MAB (n = 10) | MAV (n = 10) | MKA (n = 5) | MIN (n = 6) | MGO (n = 1) | Total87 | Percent |
|---|---|---|---|---|---|---|---|
Previous TB | 8 | 6 | 0 | 41 | 1 | 56 | 64.4% |
Clinical Bronchiectasis | 6 | 0 | 0 | 11 | 0 | 17 | 19.5% |
HIV positive | 0 | 8 | 4 | 5 | 0 | 17 | 19.5% |
COPD | 0 | 0 | 1 | 5 | 0 | 6 | 6.9% |
Hepatitis | 2 | 0 | 0 | 3 | 0 | 5 | 5.7% |
DM | 0 | 0 | 0 | 4 | 0 | 4 | 4.6% |
Hypertension | 1 | 0 | 0 | 3 | 0 | 4 | 4.6% |
Cancer | 0 | 0 | 0 | 3 | 0 | 3 | 3.4% |
AS | 0 | 1 | 0 | 0 | 0 | 1 | 1.1% |
Pulmonary fibrosis | 1 | 0 | 0 | 3 | 0 | 4 | 4.6% |
Total | 18 | 15 | 5 | 78 | 1 | 117 | Â |
Percent | 15.4% | 12.8% | 4.3% | 66.7% | 0.9% | Â | Â |